This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
UBC Division of Dermatology, Hair Research and Treatment Centre
Vancouver, British Columbia, Canada
hair density
Time frame: after 3, 6 and 9 months
percentage of subjects who experience side effects
subject assessment of treatment effect
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.